Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

Related Citations for PubMed (Select 23450068)

1.
2.

Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer.

Ströhlein MA, Bulian DR, Heiss MM.

Expert Rev Anticancer Ther. 2011 Oct;11(10):1505-8. doi: 10.1586/era.11.147.

PMID:
21999124
3.
4.

Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases.

Königsrainer I, Horvath P, Struller F, Königsrainer A, Beckert S.

J Gastric Cancer. 2014 Jun;14(2):117-22. doi: 10.5230/jgc.2014.14.2.117. Epub 2014 Jun 30.

5.

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.

Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.

In Vivo. 2010 Jan-Feb;24(1):79-84.

PMID:
20133981
6.
7.

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.

Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.

PMID:
18521686
8.

Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.

Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA.

Ann Surg Oncol. 2004 Apr;11(4):375-9. Epub 2004 Mar 15.

PMID:
15070596
9.

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.

J Clin Oncol. 2003 Oct 15;21(20):3737-43.

PMID:
14551293
10.

Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Van Sweringen HL, Hanseman DJ, Ahmad SA, Edwards MJ, Sussman JJ.

Surgery. 2012 Oct;152(4):617-24; discussion 624-5. doi: 10.1016/j.surg.2012.07.027. Epub 2012 Sep 1.

PMID:
22943843
11.

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.

Ann Surg Oncol. 2009 Feb;16(2):463-72. doi: 10.1245/s10434-008-0219-1. Epub 2008 Dec 12.

PMID:
19082859
12.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
13.

Reappraisal of the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer: a single institutional experience.

Melis A, Abboud K, Bourmaud A, Pacaut C, Bageacu S, Jacquin JP, Porcheron J, Merrouche Y, Magné N.

Bull Cancer. 2011 Jun 9. [Epub ahead of print]

PMID:
21659062
14.

Quality of life in peritoneal carcinomatosis: a prospective study in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Albertsmeier M, Hauer A, Niess H, Werner J, Graeb C, Angele MK.

Dig Surg. 2014;31(4-5):334-40. doi: 10.1159/000369259. Epub 2014 Dec 3.

PMID:
25471828
15.

[Intraperitoneal hyperthermic chemotherapy in the management of recurrent peritoneal carcinomatosis. Preliminary results in 5 patients].

Lubrano J, Huet E, Foulatier O, Michel P, Michot F, Ténière P, Scotté M.

Gastroenterol Clin Biol. 2006 Nov;30(11):1297-300. French.

16.

A critical look at local-regional management of peritoneal metastasis.

Chan CH, Cusack JC, Ryan DP.

Hematol Oncol Clin North Am. 2015 Feb;29(1):153-8. doi: 10.1016/j.hoc.2014.09.006.

PMID:
25475577
17.

Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.

Ann Surg Oncol. 2007 Oct;14(10):2790-7. Epub 2007 Jul 28.

PMID:
17661150
18.

The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer.

Muñoz-Casares FC, Rufián S, Rubio MJ, Díaz CJ, Díaz R, Casado A, Arjona A, Muñoz-Villanueva MC, Muntané J.

Clin Transl Oncol. 2009 Nov;11(11):753-9.

PMID:
19917539
19.

Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Weber T, Roitman M, Link KH.

Clin Colorectal Cancer. 2012 Sep;11(3):167-76. doi: 10.1016/j.clcc.2012.01.001. Epub 2012 Mar 6. Review.

PMID:
22397952
20.

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.

Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL.

J Cancer Res Clin Oncol. 2009 Dec;135(12):1637-45. doi: 10.1007/s00432-009-0667-4. Epub 2009 Aug 23. Review.

PMID:
19701772
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk